Mortality from pulmonary hypertension in Europe 2001-2019
Background The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes. Methods We extracted age-standardized mortality rates (ASMRs) for decedents ≥ 18 years of age from the World Health Organization Morta...
Saved in:
| Published in | BMC pulmonary medicine Vol. 24; no. 1; pp. 415 - 8 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
28.08.2024
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2466 1471-2466 |
| DOI | 10.1186/s12890-024-03235-y |
Cover
| Abstract | Background
The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes.
Methods
We extracted age-standardized mortality rates (ASMRs) for decedents ≥ 18 years of age from the World Health Organization Mortality Database, using International Classification of Diseases 10th edition codes for PH and PAH, covering the period from 2001 to 2019. The UK and European Union countries with at least 1,000,000 inhabitants and at least 75% of available data points over the study period were included.
Results
Between 2001 and 2019, in countries with available data, the median ASMR for PH increased by + 1.19 per 1,000,000 (+ 22.51%) in females and + 0.36 per 1,000,000 (+ 6.06%) in males. Out of 19 countries, 13 demonstrate an increase in female PH ASMR, and 12 reported an increase in male PH ASMR. In contrast, median PAH ASMR decreased by -0.29 per 1,000,000 (-28.74%) in females and remained relatively unchanged in males, with a minor increase of + 0.01 per 1,000,000 (+ 1.07%). Notably, there was significant inter-country heterogeneity, with countries such as Hungary, Romania, and Poland displaying results incongruous with the rest of Europe.
Conclusions
While publicly available mortality statistics for PH may be unreliable, these data suggest an overall increase in mortality across Europe from 2001 to 2019. However, mortality from PAH has shown a decrease in females and a modest increase in males. This underscores the urgent need for robust and high-quality mortality reporting, including international registries, for both PH and PAH. |
|---|---|
| AbstractList | The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes.BACKGROUNDThe incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes.We extracted age-standardized mortality rates (ASMRs) for decedents ≥ 18 years of age from the World Health Organization Mortality Database, using International Classification of Diseases 10th edition codes for PH and PAH, covering the period from 2001 to 2019. The UK and European Union countries with at least 1,000,000 inhabitants and at least 75% of available data points over the study period were included.METHODSWe extracted age-standardized mortality rates (ASMRs) for decedents ≥ 18 years of age from the World Health Organization Mortality Database, using International Classification of Diseases 10th edition codes for PH and PAH, covering the period from 2001 to 2019. The UK and European Union countries with at least 1,000,000 inhabitants and at least 75% of available data points over the study period were included.Between 2001 and 2019, in countries with available data, the median ASMR for PH increased by + 1.19 per 1,000,000 (+ 22.51%) in females and + 0.36 per 1,000,000 (+ 6.06%) in males. Out of 19 countries, 13 demonstrate an increase in female PH ASMR, and 12 reported an increase in male PH ASMR. In contrast, median PAH ASMR decreased by -0.29 per 1,000,000 (-28.74%) in females and remained relatively unchanged in males, with a minor increase of + 0.01 per 1,000,000 (+ 1.07%). Notably, there was significant inter-country heterogeneity, with countries such as Hungary, Romania, and Poland displaying results incongruous with the rest of Europe.RESULTSBetween 2001 and 2019, in countries with available data, the median ASMR for PH increased by + 1.19 per 1,000,000 (+ 22.51%) in females and + 0.36 per 1,000,000 (+ 6.06%) in males. Out of 19 countries, 13 demonstrate an increase in female PH ASMR, and 12 reported an increase in male PH ASMR. In contrast, median PAH ASMR decreased by -0.29 per 1,000,000 (-28.74%) in females and remained relatively unchanged in males, with a minor increase of + 0.01 per 1,000,000 (+ 1.07%). Notably, there was significant inter-country heterogeneity, with countries such as Hungary, Romania, and Poland displaying results incongruous with the rest of Europe.While publicly available mortality statistics for PH may be unreliable, these data suggest an overall increase in mortality across Europe from 2001 to 2019. However, mortality from PAH has shown a decrease in females and a modest increase in males. This underscores the urgent need for robust and high-quality mortality reporting, including international registries, for both PH and PAH.CONCLUSIONSWhile publicly available mortality statistics for PH may be unreliable, these data suggest an overall increase in mortality across Europe from 2001 to 2019. However, mortality from PAH has shown a decrease in females and a modest increase in males. This underscores the urgent need for robust and high-quality mortality reporting, including international registries, for both PH and PAH. The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes. We extracted age-standardized mortality rates (ASMRs) for decedents ≥ 18 years of age from the World Health Organization Mortality Database, using International Classification of Diseases 10th edition codes for PH and PAH, covering the period from 2001 to 2019. The UK and European Union countries with at least 1,000,000 inhabitants and at least 75% of available data points over the study period were included. Between 2001 and 2019, in countries with available data, the median ASMR for PH increased by + 1.19 per 1,000,000 (+ 22.51%) in females and + 0.36 per 1,000,000 (+ 6.06%) in males. Out of 19 countries, 13 demonstrate an increase in female PH ASMR, and 12 reported an increase in male PH ASMR. In contrast, median PAH ASMR decreased by -0.29 per 1,000,000 (-28.74%) in females and remained relatively unchanged in males, with a minor increase of + 0.01 per 1,000,000 (+ 1.07%). Notably, there was significant inter-country heterogeneity, with countries such as Hungary, Romania, and Poland displaying results incongruous with the rest of Europe. While publicly available mortality statistics for PH may be unreliable, these data suggest an overall increase in mortality across Europe from 2001 to 2019. However, mortality from PAH has shown a decrease in females and a modest increase in males. This underscores the urgent need for robust and high-quality mortality reporting, including international registries, for both PH and PAH. The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes. We extracted age-standardized mortality rates (ASMRs) for decedents [greater than or equal to] 18 years of age from the World Health Organization Mortality Database, using International Classification of Diseases 10th edition codes for PH and PAH, covering the period from 2001 to 2019. The UK and European Union countries with at least 1,000,000 inhabitants and at least 75% of available data points over the study period were included. Between 2001 and 2019, in countries with available data, the median ASMR for PH increased by + 1.19 per 1,000,000 (+ 22.51%) in females and + 0.36 per 1,000,000 (+ 6.06%) in males. Out of 19 countries, 13 demonstrate an increase in female PH ASMR, and 12 reported an increase in male PH ASMR. In contrast, median PAH ASMR decreased by -0.29 per 1,000,000 (-28.74%) in females and remained relatively unchanged in males, with a minor increase of + 0.01 per 1,000,000 (+ 1.07%). Notably, there was significant inter-country heterogeneity, with countries such as Hungary, Romania, and Poland displaying results incongruous with the rest of Europe. While publicly available mortality statistics for PH may be unreliable, these data suggest an overall increase in mortality across Europe from 2001 to 2019. However, mortality from PAH has shown a decrease in females and a modest increase in males. This underscores the urgent need for robust and high-quality mortality reporting, including international registries, for both PH and PAH. Background The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes. Methods We extracted age-standardized mortality rates (ASMRs) for decedents ≥ 18 years of age from the World Health Organization Mortality Database, using International Classification of Diseases 10th edition codes for PH and PAH, covering the period from 2001 to 2019. The UK and European Union countries with at least 1,000,000 inhabitants and at least 75% of available data points over the study period were included. Results Between 2001 and 2019, in countries with available data, the median ASMR for PH increased by + 1.19 per 1,000,000 (+ 22.51%) in females and + 0.36 per 1,000,000 (+ 6.06%) in males. Out of 19 countries, 13 demonstrate an increase in female PH ASMR, and 12 reported an increase in male PH ASMR. In contrast, median PAH ASMR decreased by -0.29 per 1,000,000 (-28.74%) in females and remained relatively unchanged in males, with a minor increase of + 0.01 per 1,000,000 (+ 1.07%). Notably, there was significant inter-country heterogeneity, with countries such as Hungary, Romania, and Poland displaying results incongruous with the rest of Europe. Conclusions While publicly available mortality statistics for PH may be unreliable, these data suggest an overall increase in mortality across Europe from 2001 to 2019. However, mortality from PAH has shown a decrease in females and a modest increase in males. This underscores the urgent need for robust and high-quality mortality reporting, including international registries, for both PH and PAH. BackgroundThe incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes.MethodsWe extracted age-standardized mortality rates (ASMRs) for decedents ≥ 18 years of age from the World Health Organization Mortality Database, using International Classification of Diseases 10th edition codes for PH and PAH, covering the period from 2001 to 2019. The UK and European Union countries with at least 1,000,000 inhabitants and at least 75% of available data points over the study period were included.ResultsBetween 2001 and 2019, in countries with available data, the median ASMR for PH increased by + 1.19 per 1,000,000 (+ 22.51%) in females and + 0.36 per 1,000,000 (+ 6.06%) in males. Out of 19 countries, 13 demonstrate an increase in female PH ASMR, and 12 reported an increase in male PH ASMR. In contrast, median PAH ASMR decreased by -0.29 per 1,000,000 (-28.74%) in females and remained relatively unchanged in males, with a minor increase of + 0.01 per 1,000,000 (+ 1.07%). Notably, there was significant inter-country heterogeneity, with countries such as Hungary, Romania, and Poland displaying results incongruous with the rest of Europe.ConclusionsWhile publicly available mortality statistics for PH may be unreliable, these data suggest an overall increase in mortality across Europe from 2001 to 2019. However, mortality from PAH has shown a decrease in females and a modest increase in males. This underscores the urgent need for robust and high-quality mortality reporting, including international registries, for both PH and PAH. Background The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes. Methods We extracted age-standardized mortality rates (ASMRs) for decedents [greater than or equal to] 18 years of age from the World Health Organization Mortality Database, using International Classification of Diseases 10th edition codes for PH and PAH, covering the period from 2001 to 2019. The UK and European Union countries with at least 1,000,000 inhabitants and at least 75% of available data points over the study period were included. Results Between 2001 and 2019, in countries with available data, the median ASMR for PH increased by + 1.19 per 1,000,000 (+ 22.51%) in females and + 0.36 per 1,000,000 (+ 6.06%) in males. Out of 19 countries, 13 demonstrate an increase in female PH ASMR, and 12 reported an increase in male PH ASMR. In contrast, median PAH ASMR decreased by -0.29 per 1,000,000 (-28.74%) in females and remained relatively unchanged in males, with a minor increase of + 0.01 per 1,000,000 (+ 1.07%). Notably, there was significant inter-country heterogeneity, with countries such as Hungary, Romania, and Poland displaying results incongruous with the rest of Europe. Conclusions While publicly available mortality statistics for PH may be unreliable, these data suggest an overall increase in mortality across Europe from 2001 to 2019. However, mortality from PAH has shown a decrease in females and a modest increase in males. This underscores the urgent need for robust and high-quality mortality reporting, including international registries, for both PH and PAH. Keywords: Pulmonary hypertension, Pulmonary arterial hypertension, Mortality, Europe Abstract Background The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes. Methods We extracted age-standardized mortality rates (ASMRs) for decedents ≥ 18 years of age from the World Health Organization Mortality Database, using International Classification of Diseases 10th edition codes for PH and PAH, covering the period from 2001 to 2019. The UK and European Union countries with at least 1,000,000 inhabitants and at least 75% of available data points over the study period were included. Results Between 2001 and 2019, in countries with available data, the median ASMR for PH increased by + 1.19 per 1,000,000 (+ 22.51%) in females and + 0.36 per 1,000,000 (+ 6.06%) in males. Out of 19 countries, 13 demonstrate an increase in female PH ASMR, and 12 reported an increase in male PH ASMR. In contrast, median PAH ASMR decreased by -0.29 per 1,000,000 (-28.74%) in females and remained relatively unchanged in males, with a minor increase of + 0.01 per 1,000,000 (+ 1.07%). Notably, there was significant inter-country heterogeneity, with countries such as Hungary, Romania, and Poland displaying results incongruous with the rest of Europe. Conclusions While publicly available mortality statistics for PH may be unreliable, these data suggest an overall increase in mortality across Europe from 2001 to 2019. However, mortality from PAH has shown a decrease in females and a modest increase in males. This underscores the urgent need for robust and high-quality mortality reporting, including international registries, for both PH and PAH. |
| ArticleNumber | 415 |
| Audience | Academic |
| Author | Salciccioli, Justin D. Jani, Chinmay Singh, Harpreet Marshall, Dominic C. Howard, Luke S. Shalhoub, Joseph Hartley, Adam |
| Author_xml | – sequence: 1 givenname: Adam surname: Hartley fullname: Hartley, Adam email: adam.hartley12@imperial.ac.uk organization: National Heart and Lung Institute, Imperial College, Hammersmith Hospital, Medical Data Research Collaborative – sequence: 2 givenname: Harpreet surname: Singh fullname: Singh, Harpreet organization: Medical Data Research Collaborative, Division of Pulmonary and Critical Care Medicine, Medical College of Wisconsin – sequence: 3 givenname: Chinmay surname: Jani fullname: Jani, Chinmay organization: Medical Data Research Collaborative, Department of Medicine, Mount Auburn Hospital/Beth Israel Lahey Health, Harvard Medical School – sequence: 4 givenname: Justin D. surname: Salciccioli fullname: Salciccioli, Justin D. organization: Medical Data Research Collaborative, Division of Pulmonary and Critical Care, Brigham and Women’s Hospital – sequence: 5 givenname: Joseph surname: Shalhoub fullname: Shalhoub, Joseph organization: Medical Data Research Collaborative, Imperial College Healthcare NHS Trust, Department of Surgery and Cancer, Imperial College London – sequence: 6 givenname: Luke S. surname: Howard fullname: Howard, Luke S. organization: National Heart and Lung Institute, Imperial College, Hammersmith Hospital – sequence: 7 givenname: Dominic C. surname: Marshall fullname: Marshall, Dominic C. organization: National Heart and Lung Institute, Imperial College, Hammersmith Hospital, Medical Data Research Collaborative |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39198769$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstu3SAQQFGVqnm0P9BFZambbpwyYPNYVVGUppFSdZM9woBvuLLBBbvS_fuQOK9bVRUL0HDmwMAco4MQg0PoI-BTAMG-ZiBC4hqTpsaU0LbevUFH0HCoScPYwav1ITrOeYsxcNHSd-iQSpCCM3mE5M-YZj34eVf1KY7VtAxjDDrtqtvd5NLsQvYxVD5UF0uKk6tIsdQEg3yP3vZ6yO7D43yCbr5f3Jz_qK9_XV6dn13Xpm3lXBPGMDjZkBZ6I4gjhkoKBhyVVoi2I9JpzrXV0HHbdIb3tARdx3qgzAh6gq5WrY16q6bkx3I5FbVXD4GYNkqn2ZvBKWZpJ_uGc0psIwQpXmsIsR3uOG8bV1zfVte0dKOzxoU56WFPur8T_K3axD8KgLZQnqwYvjwaUvy9uDyr0WfjhkEHF5esKJYSGsAtFPTzX-g2LimUp1IUyp8JRoG8UBtdKvChj-Vgcy9VZwILyjkGXKjTf1BlWDd6U7qi9yW-l_DpdaXPJT59fAHICpgUc06uf0YAq_vuUmt3qXJT9dBdaleS6JqUCxw2Lr2U9J-sO8zJzjI |
| Cites_doi | 10.1164/rccm.200510-1668OC 10.1093/eurheartj/ehac237 10.1016/j.ijcard.2012.10.026 10.1161/CIRCOUTCOMES.117.003973 10.1155/2014/105864 10.1152/ajplung.00337.2013 10.1183/09031936.00116313 10.1056/NEJMoa2008470 10.1093/eurheartj/ehv317 10.1183/16000617.0050-2019 10.3390/jcm9010173 10.1378/chest.10-0837 10.1016/j.chest.2021.02.012 10.1183/09031936.00092306 10.1016/S2213-2600(17)30305-3 10.1093/eurheartj/suz211 10.1111/bph.12281 10.1378/chest.14-0527 10.21037/cdt-21-351 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024 |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12890-024-03235-y |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2466 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_6d3b9f47732d4882a77dc22db0b7754e PMC11351198 A808377010 39198769 10_1186_s12890_024_03235_y |
| Genre | Journal Article |
| GeographicLocations | Europe Poland United Kingdom Romania Hungary United Kingdom--UK Spain Czech Republic Belgium Finland Italy Slovenia Lithuania Croatia |
| GeographicLocations_xml | – name: Europe – name: United Kingdom – name: Poland – name: Hungary – name: Romania – name: Slovenia – name: Italy – name: Spain – name: Croatia – name: Lithuania – name: United Kingdom--UK – name: Finland – name: Czech Republic – name: Belgium |
| GrantInformation_xml | – fundername: Wellcome Trust grantid: 220572/Z/20/Z funderid: http://dx.doi.org/10.13039/100010269 – fundername: Wellcome Trust grantid: 220572/Z/20/Z – fundername: Wellcome Trust |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7TO 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c559t-26601e94251fc82e2c3931c1e39d885b29ea77ada1b7d4bc7f35b2eb6f136c83 |
| IEDL.DBID | M48 |
| ISSN | 1471-2466 |
| IngestDate | Wed Aug 27 01:22:52 EDT 2025 Thu Aug 21 18:32:07 EDT 2025 Thu Sep 04 15:22:42 EDT 2025 Sat Jul 26 02:07:09 EDT 2025 Tue Jun 17 22:04:35 EDT 2025 Tue Jun 10 21:04:18 EDT 2025 Sun Aug 17 02:24:25 EDT 2025 Tue Jul 01 02:40:37 EDT 2025 Sat Sep 06 07:21:56 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Pulmonary arterial hypertension Mortality Europe Pulmonary hypertension |
| Language | English |
| License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c559t-26601e94251fc82e2c3931c1e39d885b29ea77ada1b7d4bc7f35b2eb6f136c83 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12890-024-03235-y |
| PMID | 39198769 |
| PQID | 3102486312 |
| PQPubID | 44785 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_6d3b9f47732d4882a77dc22db0b7754e pubmedcentral_primary_oai_pubmedcentral_nih_gov_11351198 proquest_miscellaneous_3099141051 proquest_journals_3102486312 gale_infotracmisc_A808377010 gale_infotracacademiconefile_A808377010 pubmed_primary_39198769 crossref_primary_10_1186_s12890_024_03235_y springer_journals_10_1186_s12890_024_03235_y |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08-28 |
| PublicationDateYYYYMMDD | 2024-08-28 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-28 day: 28 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC pulmonary medicine |
| PublicationTitleAbbrev | BMC Pulm Med |
| PublicationTitleAlternate | BMC Pulm Med |
| PublicationYear | 2024 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | DT Wijeratne (3235_CR7) 2018; 11 A Waxman (3235_CR12) 2021; 384 N Galiè (3235_CR1) 2016; 37 G Kopeć (3235_CR4) 2020; 9 O Sitbon (3235_CR21) 2014; 43 T Lahm (3235_CR24) 2014; 307 3235_CR15 AJ Peacock (3235_CR5) 2007; 30 M Humbert (3235_CR2) 2022; 43 3235_CR8 MM Hoeper (3235_CR25) 2013; 168 K Swinnen (3235_CR17) 2019; 28 AS Kaemmerer (3235_CR18) 2021; 11 KM Mair (3235_CR23) 2014; 171 G Strange (3235_CR3) 2012; 98 3235_CR22 G Simonneau (3235_CR11) 2019; 21 OB Ahmad (3235_CR14) 2001 CD Vizza (3235_CR19) 2021; 160 J Link (3235_CR16) 2011; 139 M Humbert (3235_CR6) 2006; 173 3235_CR20 MG George (3235_CR10) 2014; 146 A Mehari (3235_CR9) 2014; 2014 HA Ghofrani (3235_CR13) 2017; 5 |
| References_xml | – volume: 173 start-page: 1023 issue: 9 year: 2006 ident: 3235_CR6 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200510-1668OC – volume: 43 start-page: 3618 issue: 38 year: 2022 ident: 3235_CR2 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehac237 – volume: 168 start-page: 871 issue: 2 year: 2013 ident: 3235_CR25 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2012.10.026 – volume: 11 start-page: e003973 issue: 2 year: 2018 ident: 3235_CR7 publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.117.003973 – volume: 2014 start-page: 105864 year: 2014 ident: 3235_CR9 publication-title: Pulm Med doi: 10.1155/2014/105864 – volume: 307 start-page: L7 issue: 1 year: 2014 ident: 3235_CR24 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00337.2013 – volume: 43 start-page: 1691 issue: 6 year: 2014 ident: 3235_CR21 publication-title: Eur Respir J doi: 10.1183/09031936.00116313 – volume: 384 start-page: 325 issue: 4 year: 2021 ident: 3235_CR12 publication-title: N Engl J Med doi: 10.1056/NEJMoa2008470 – volume: 37 start-page: 67 issue: 1 year: 2016 ident: 3235_CR1 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv317 – volume: 28 start-page: 190050 issue: 154 year: 2019 ident: 3235_CR17 publication-title: Eur Respir Rev. doi: 10.1183/16000617.0050-2019 – ident: 3235_CR22 – ident: 3235_CR20 – volume-title: Age standardization of rates: a new WHO standard year: 2001 ident: 3235_CR14 – volume: 9 start-page: 173 issue: 1 year: 2020 ident: 3235_CR4 publication-title: J Clin Med. doi: 10.3390/jcm9010173 – volume: 139 start-page: 497 issue: 3 year: 2011 ident: 3235_CR16 publication-title: Chest doi: 10.1378/chest.10-0837 – volume: 160 start-page: 678 issue: 2 year: 2021 ident: 3235_CR19 publication-title: Chest doi: 10.1016/j.chest.2021.02.012 – volume: 30 start-page: 104 issue: 1 year: 2007 ident: 3235_CR5 publication-title: Eur Respir J doi: 10.1183/09031936.00092306 – volume: 5 start-page: 785 issue: 10 year: 2017 ident: 3235_CR13 publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(17)30305-3 – ident: 3235_CR15 – volume: 21 start-page: K4 issue: Suppl K year: 2019 ident: 3235_CR11 publication-title: Eur Heart J Suppl doi: 10.1093/eurheartj/suz211 – volume: 171 start-page: 567 issue: 3 year: 2014 ident: 3235_CR23 publication-title: Br J Pharmacol doi: 10.1111/bph.12281 – ident: 3235_CR8 – volume: 98 start-page: 1805 issue: 24 year: 2012 ident: 3235_CR3 publication-title: Heart (British Cardiac Society) – volume: 146 start-page: 476 issue: 2 year: 2014 ident: 3235_CR10 publication-title: Chest doi: 10.1378/chest.14-0527 – volume: 11 start-page: 1255 issue: 6 year: 2021 ident: 3235_CR18 publication-title: Cardiovasc Diagn Ther doi: 10.21037/cdt-21-351 |
| SSID | ssj0017853 |
| Score | 2.360412 |
| Snippet | Background
The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor... The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes. We... Background The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor... The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes. We... BackgroundThe incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor... The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor... Abstract Background The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 415 |
| SubjectTerms | Adult Age Aged Aged, 80 and over Analysis Cardiac catheterization Care and treatment Complications and side effects Critical Care Medicine Databases, Factual Disease Dosage and administration Echocardiography Epidemiology Europe Europe - epidemiology Female Females Health aspects Humans Hungary Hypertension Hypertension, Pulmonary - epidemiology Hypertension, Pulmonary - mortality Incidence Intensive Internal Medicine Male Males Medical prognosis Medicine Medicine & Public Health Middle Aged Missing data Mortality Patient outcomes Pneumology/Respiratory System Poland Population Prognosis Pulmonary arterial hypertension Pulmonary arteries Pulmonary hypertension Quality standards Romania Sex Distribution Treprostinil United Kingdom |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB5KDiGX0qRp6-aBA4UeWhFLsvU4JqEhBLanFHITepkEijdsdg_77zuS7U2cUnrJ1ZJB_mZGM-MZfQL4EtDKXG0b0lYNI7UPkVjlLeHKU5v4rXiVDgrPfoqrX_X1bXP77Kqv1BPW0wP3wJ2KwJ1uayk5C6hszEoZPGPBVS6Rt8W0-1a6GpOpoX4g0QuNR2SUOH2kqZ5G0B-RijPekPXEDWW2_r_35GdO6WXD5IuqaXZGl-_g7RBFlmf96nfhTez2YHs21Mnfg57lqBoj7DKdHykfVr9R3exiXd5h3rnIXevzrrzvyv5vfJl7ntBL6324ufxxc3FFhksSiMdkYEnQwVY0ajQ92nrFIvNcc-pp5Doo1TimI0Jmg6VOhtp52XJ8GJ1oKRde8Q-w1c27-AnKumExph1SSIpBVnAuc8VHXgvqtA4FfBshMw89FYbJKYQSpgfYIMAmA2zWBZwnVDczE411foDCNYNwzf-EW8DXJBOTjA2B93Y4M4ALTrRV5kzhAqXEnLKAw8lMNBI_HR6lagYjfTQY2bJaCU5ZASeb4fRmajzr4nyFczCCzq2wtICPvRJsPonr9MdG6ALURD0m3zwd6e7vMoU3pbmAqwr4PmrS07r-Dern1wD1AHZYtgTcItUhbC0Xq3iEkdXSHWcj-gMkyBs5 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1Ni9UwcNAVxIv4bXWVCoIHDdskbT5OsorLIjxPK7xbyFfdBWmf7-Pw_r2TtH1rV_SapCWZzPdMZgDeBqQyV9uGtFXDSO1DJFZ5S7jy1Kb6VrxKD4UX38T59_rrslmODrfNmFY58cTMqEPvk4_8BNUQVivBKfu4-kVS16gUXR1baNyGOxQ1kdS6QS4PBldqPM-nhzJKnGxoiqoR_A-pOOMN2c-EUa7Z_zdn_kM03UybvBE7zSLp7AHcH3XJ8nS4_IdwK3aP4O5ijJY_Br3IujXq2WV6RVKudj_xFHa9Ly_R-lzn3PW-K6-6cvDJlznzCWW1fgIXZ18uPp-TsVUC8WgSbAmK2YpGjQRIW69YZJ5rTj2NXAelGsd0tFLaYKmToXZethwHoxMt5cIr_hSOur6Lz6GsGxZj4pNCUlS1gnO5YnzktaBO61DA-wlkZjUUxDDZkFDCDAA2CGCTAWz2BXxKUD2sTMWs80C__mFG2jAicKfbWkrOAvIThjsNnrHgKpfq88UC3qU7MYnkEPDeji8HcMOpeJU5VbhBKdGyLOB4thJJxc-np1s1I6luzDViFfDmMJ2-TOlnXex3uAb16JwQSwt4NiDB4UhcJ7-N0AWoGXrMzjyf6a4ucyFvSnMYVxXwYcKk6339G6gv_n-Ml3CPZRxHFqiO4Wi73sVXqDlt3etMHr8BrngSzQ priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NSxwxFH9YhdJLsdW2U20ZoeDBhk6SmXwcdalIYT1Z8BbyNSiUWVl3D_vf9yUzuzraHrzmA5L3nXnv_QbgW0Atc7VtSFs1jNQ-RGKVt4QrT23Ct-JVahSeXoqL3_Wv6-Z6gMlJvTCP8_dUiR_3NGXCCHoSUnHGG7J6BTsNGt4kzRMx2WQMJPqddVPMP_eNHE_G539uhR-5oaclkk_ypNn9nO_C2yFuLE97Rr-Drdi9h9fTITO-B3qa42iMqcvUMVLeLf-ggNn5qrzBl-Y816nPuvK2K_vv72WuckK_rPfh6vzn1eSCDL9FIB7D_wVBl1rRqFHZaOsVi8xzzamnkeugVOOYjlZKGyx1MtTOy5bjYHSipVx4xT_Adjfr4ico64bFmGyikBTDquBcRoePvBbUaR0KOFmTzNz14BcmPxqUMD2BDRLYZAKbVQFniaqblQm4Og8gP82gB0YE7nRbS8lZQNvB8KTBMxZc5RIWXyzgOPHEJPVCwns7dAnggRNQlTlVeEAp8RVZwOFoJaqFH0-vuWoGtbw3GMuyWglOWQFHm-m0M5WadXG2xDUYM-fiV1rAx14INlfiOn2jEboANRKP0Z3HM93tTQbtpjSnbFUB39eS9HCu_xP188uWH8AblmUezZ86hO3FfBm_YNS0cF-zuvwF0tYMSA priority: 102 providerName: Springer Nature |
| Title | Mortality from pulmonary hypertension in Europe 2001-2019 |
| URI | https://link.springer.com/article/10.1186/s12890-024-03235-y https://www.ncbi.nlm.nih.gov/pubmed/39198769 https://www.proquest.com/docview/3102486312 https://www.proquest.com/docview/3099141051 https://pubmed.ncbi.nlm.nih.gov/PMC11351198 https://doaj.org/article/6d3b9f47732d4882a77dc22db0b7754e |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFD70AmMvY_d564IHgz1s2izJ1uVhjCa0lEHKKC2EvQjrkrVQnC5NYPn3O1LsdO66h70YYilGOjpXnaNPAG89Spkt64pMi4qR0vlAauVqwpWjdcS34kU8KDw-Fkdn5ddJNdmC7rqjloDXd4Z28T6ps_nlx18_V19Q4D8ngVfi0zWN2TKC1oYUnPGKrLZhN-WLYilfeZNVkCqhUlJUyISVQnSHaO78Rs9QJTz_v7X2H2brdknlrbxqMleHD-FB62fm-2vGeARboXkM98ZtJv0J6HGaMvrgeTxhkl8tL5Eh6_kqP8fIdJ7q2mdNftHk6_36PFVFoR3XT-H08OB0dETaaxSIw3BhQdAEFzRoFE46dYoF5rjm1NHAtVeqskyHWsra19RKX1onpxxfBiumlAun-DPYaWZNeAF5WbEQog4VkqIb5q1NaPKBl4JarX0G7zuSmas1WIZJQYYSZk1ggwQ2icBmlcEwUnXTMwJdpxez-Q_Tyo0Rnls9LaXkzKOuYThS7xjztrARuy9k8C6uiYkMgoR3dXuqAAccga3MvsIBSolRZwZ7vZ4oRq7f3K2q6bjQoO_LSiU4ZRm82TTHf8bStCbMltgHfexULEszeL5mgs2UuI57OkJnoHrs0Ztzv6W5OE8g35SmFK_K4EPHSTfj-jdRX_7XEryC-yyxPGpLtQc7i_kyvEYna2EHsC0ncgC7w4Pjbyf4ayRGg7RhMUgyhc-T4fffteUhnw |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1JbxMxFH4qqQS9INYyUGCQQBzAamzPYh8q1EKrlDYRQkHqzRovQytVk5BFKD-O_8azZyZliuDW69iJ7M9vs98G8Noil-mkSEnZTxlJjHWkEKYgXBha-PpWvO8ThYejbPAt-XyWnm3ArzYXxodVtjIxCGo7Mf6NfBfNEJaIjFP2YfqD-K5R3rvattAomtYKdi-UGGsSO07c6ide4eZ7x5_wvN8wdnQ4_jggTZcBYtCaXhDUUH3qJNIuLY1gjhkuOTXUcWmFSDWTrsjzwhZU5zbRJi85fnQ6KynPjOD4t7dgM_HvJz3YPDgcffm6dmPkqAzbTB2R7c6pd-sR3Ajpc8ZTsupow9A04G_V8IduvB63ec15G3Ti0T242xiz8X5Nffdhw1UP4Pawcdc_BDkMxj0a-rFPY4mny0uEsZit4nO8_s5C8Pykii-quHYKxCH0Co0F-QjGN4HiY-hVk8o9gThJmXNeUGc5RVvPah1K1jueZFRLaSN410KmpnVFDhVuMiJTNcAKAVYBYLWK4MCjup7pq2mHD5PZd9Uwp8os17JM8pwziwKN4UqtYczqvvYFAl0Eb_2ZKM_zCLwpmtQFXLCvnqX2BS4wz_FqG8FOZybyqukOt6eqGlkxV1eUHcGr9bD_pY9_q9xkiXPQkA8RuTSC7ZoI1lvi0j8cZTIC0SGPzp67I9XFeagkTmnwI4sI3reUdLWuf4P69P_beAl3BuPhqTo9Hp08gy0W6B3lsdiB3mK2dM_RjFvoFw2zxKBumD1_Ayc7Vbc |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VVqq4IN4ESgkSEgewGtuJH8eydFUeW3EoUm9W_AithLKr7e5h_z1jJ1maAgeufkjj8bycmfkC8MajltmyrkhTVIyUzgdSK1cTrhytI74VL2Kj8OxMnH4vP19UFze6-FO1-5CS7HoaIkpTuzpa-KZTcSWOrmnMjxH0L6TgjFdkcwf2IlZXLOqbiMk2jyDRGw2tMn_dN3JHCbX_T9t8wzndLpy8lT1NTml6H-710WR-3F3_A9gJ7UPYn_X58kegZym6xkg7j30k-WL9E8WuXm7yS3x_LlP1-rzNr9q8-yqfp9on9Nb6MZxPT84np6T_WQJx-ChYEXS0BQ0aVZA2TrHAHNecOhq49kpVlulQS1n7mlrpS-tkw3EwWNFQLpziT2C3nbfhGeRlxUKIllJIisGWtzZhxgdeCmq19hm8G1hmFh0khklPCSVMx2CDDDaJwWaTwYfI1e3KCGedBubLH6bXDiM8t7oppeTMo0VhSKl3jHlb2IjQFzJ4G-_ERKVDxru67x1AgiN8lTlWSKCU-LbM4GC0EpXFjaeHWzW9sl4bjHBZqQSnLIPX2-m4MxagtWG-xjUYSaeSWJrB004ItkfiOn65EToDNRKP0ZnHM-3VZYLypjQlclUG7wdJ-k3Xv5n6_P-Wv4L9bx-n5uunsy8v4C5L4o_2UR3A7mq5Di8xrFrZw6Q5vwDc6ReH |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mortality+from+pulmonary+hypertension+in+Europe+2001-2019&rft.jtitle=BMC+pulmonary+medicine&rft.au=Hartley%2C+Adam&rft.au=Singh%2C+Harpreet&rft.au=Jani%2C+Chinmay&rft.au=Salciccioli%2C+Justin+D.&rft.date=2024-08-28&rft.issn=1471-2466&rft.eissn=1471-2466&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs12890-024-03235-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12890_024_03235_y |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2466&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2466&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2466&client=summon |